Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

LEMAITRE VASCULAR, INC.

(LMAT)
  Report
Delayed Nasdaq  -  04:00 2022-12-08 pm EST
46.51 USD   +1.62%
11/22LeMaitre to Present at Upcoming Investor Conferences
AQ
11/16LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
11/08LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

LeMaitre Vascular Will Announce First Quarter 2017 Earnings Results on April 26, 2017

04/12/2017 | 04:16pm EST

BURLINGTON, Mass., April 12, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2017 financial results on Wednesday, April 26, 2017, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.

Access to the live call is available by dialing 844-239-5284 (+1-512-961-6497 for international callers), passcode 7880736. The call can also be accessed live or via replay through a webcast at www.lemaitre.com/investor

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.

LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc.
Steven Chehames
Investor Relations
+1-781-425-1659
schehames@lemaitre.com
http://www.lemaitre.com

Primary Logo


ę GlobeNewswire 2017
All news about LEMAITRE VASCULAR, INC.
11/22LeMaitre to Present at Upcoming Investor Conferences
AQ
11/16LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
11/08LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and ..
AQ
11/02LeMaitre to Present at Upcoming Investor Conferences
AQ
10/31North American Morning Briefing: Futures Pull -3-
DJ
10/28Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform
MT
10/27Lemaitre : Q3 Earnings Snapshot
AQ
10/27Transcript : LeMaitre Vascular, Inc., Q3 2022 Earnings Call, Oct 27, 2022
CI
10/27LeMaitre Vascular, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
10/27Earnings Flash (LMAT) LEMAITRE VASCULAR Reports Q3 Revenue $39M
MT
More news
Analyst Recommendations on LEMAITRE VASCULAR, INC.
More recommendations
Financials (USD)
Sales 2022 162 M - -
Net income 2022 20,7 M - -
Net Debt 2022 - - -
P/E ratio 2022 50,0x
Yield 2022 1,08%
Capitalization 1 023 M 1 023 M -
Capi. / Sales 2022 6,32x
Capi. / Sales 2023 5,91x
Nbr of Employees 469
Free-Float 82,5%
Chart LEMAITRE VASCULAR, INC.
Duration : Period :
LeMaitre Vascular, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LEMAITRE VASCULAR, INC.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 46,51 $
Average target price 58,83 $
Spread / Average Target 26,5%
EPS Revisions
Managers and Directors
George W. LeMaitre Chairman & Chief Executive Officer
David B. Roberts Chief Financial Officer
Joseph P. Pellegrino Chief Financial Officer, Secretary & Director
Jonathan W. Ngau Director-Information Technology
Ryan H. Connelly Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
LEMAITRE VASCULAR, INC.-8.88%1 023
THERMO FISHER SCIENTIFIC-14.88%219 934
DANAHER CORPORATION-18.47%195 269
INTUITIVE SURGICAL, INC.-24.29%94 693
BOSTON SCIENTIFIC CORPORATION7.42%65 356
SIEMENS HEALTHINEERS AG-24.89%57 925